Robert G. Roeder
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Robert G. Roeder has a total of 55 co-authors. Here are the top co-authors by number of shared publications:
Zhengxin Wang
Laboratory of Biochemistry and Molecular Biology, The Rockefeller University, 1230 York Avenue, New York, NY 10021
8 shared publicationsMohamed Guermah
Laboratory of Biochemistry and Molecular Biology, The Rockefeller University, New York, NY 10021
5 shared publicationsYong Tao
Laboratory of Biochemistry and Molecular Biology, The Rockefeller University, New York, New York 10021
5 shared publicationsErnest Martinez
Laboratories of *Biochemistry and Molecular Biology, and† Mass Spectrometry and Gaseous Ion Chemistry, The Rockefeller University, New York, NY 10021
4 shared publicationsHua Xiao
The Rockefeller University
4 shared publicationsChao-Xing Yuan
Laboratory of Biochemistry and Molecular Biology, The Rockefeller University, New York, NY 10021
3 shared publications
Latest Publications
- Open Access
- 1 July 2002
- Published by Springer Nature in The EMBO Journal
- Vol. 21 (13) , 3464-3475
The TRAP100 component of the TRAP/Mediator complex is essential in broad transcriptional events and development
The multisubunit TRAP/Mediator complex is a mammalian counterpart of the yeast Mediator that shows diverse coactivation functions. Genetic ablation of the murine TRAP100 component of this complex has revealed that it is not essential for cell viability per se . However, null mutant mice die at an early developmental stage with severe malformations, and cultured TRAP100‐deficient cells exhibit attenuated functions of a wide variety of transcriptional activators on ectopic reporters. The TRAP100‐deficient TRAP/Mediator complex also lacks TRAP95 and TRAP150β/SUR2, which together with TRAP100 may form a submodule, and contains a reduced amount of SRB10/CDK8. Nevertheless, the residual complex shows unaltered binding both to RNA polymerase II and, with the exception of the oncoprotein E1A, to various activators. These findings suggest that TRAP/Mediator is broadly involved in transcription and that a TRAP100‐containing submodule plays a secondary role, beyond primary activator interactions and RNA polymerase recruitment by the TRAP complex, in magnifying effects of activators on the general transcriptional machinery.
- 1 July 2002
- Published by Springer Nature in The EMBO Journal
- Vol. 21 (13) , 3464-3475
Open AccessThe TRAP100 component of the TRAP/Mediator complex is essential in broad transcriptional events and development
The multisubunit TRAP/Mediator complex is a mammalian counterpart of the yeast Mediator that shows diverse coactivation functions. Genetic ablation of the murine TRAP100 component of this complex has revealed that it is not essential for cell viability per se . However, null mutant mice die at an early developmental stage with severe malformations, and cultured TRAP100‐deficient cells exhibit attenuated functions of a wide variety of transcriptional activators on ectopic reporters. The TRAP100‐deficient TRAP/Mediator complex also lacks TRAP95 and TRAP150β/SUR2, which together with TRAP100 may form a submodule, and contains a reduced amount of SRB10/CDK8. Nevertheless, the residual complex shows unaltered binding both to RNA polymerase II and, with the exception of the oncoprotein E1A, to various activators. These findings suggest that TRAP/Mediator is broadly involved in transcription and that a TRAP100‐containing submodule plays a secondary role, beyond primary activator interactions and RNA polymerase recruitment by the TRAP complex, in magnifying effects of activators on the general transcriptional machinery.
- 1 April 2002
- Published by Taylor & Francis in Molecular and Cellular Biology
- Vol. 22 (8) , 2842-2852
Requirement of TRAP/Mediator for Both Activator-Independent and Activator-Dependent Transcription in Conjunction with TFIID-Associated TAFIIs
The multiprotein human TRAP/Mediator complex, which is phylogenetically related to the yeast SRB/Mediator coactivator, facilitates activation through a wide variety of transcriptional activators. However, it remains unclear how TRAP/Mediator functions in the context of other coactivators. Here we have identified a previously uncharacterized integral subunit (TRAP25) of the complex that is apparently metazoan specific. An antibody that is specific for TRAP25 allowed quantitative immunodepletion of essentially all TRAP/Mediator components from HeLa nuclear extract, without detectably affecting levels of RNA polymerase II and corresponding general transcription factors. Surprisingly, the TRAP/Mediator-depleted nuclear extract displayed severely reduced levels of both basal and activator-dependent transcription from DNA templates. Both activities were efficiently restored upon readdition of purified TRAP/Mediator. Moreover, restoration of basal and activator-dependent transcription to extracts that were simultaneously depleted of TRAP/Mediator and TFIID (TBP plus the major TAFIIs) required addition of both TBP and associated TAFIIs, as well as TRAP/Mediator. These observations indicate that TAFIIs and Mediator are jointly required for both basal and activated transcription in the context of a more physiological complement of nuclear proteins. We propose a close mechanistic linkage between these components that most likely operates at the level of combined effects on the general transcription machinery and, in addition, a direct role for Mediator in relaying activation signals to this machinery.
- 1 April 2002
- Published by Taylor & Francis in Molecular and Cellular Biology
- Vol. 22 (8) , 2842-2852
Requirement of TRAP/Mediator for Both Activator-Independent and Activator-Dependent Transcription in Conjunction with TFIID-Associated TAFIIs
The multiprotein human TRAP/Mediator complex, which is phylogenetically related to the yeast SRB/Mediator coactivator, facilitates activation through a wide variety of transcriptional activators. However, it remains unclear how TRAP/Mediator functions in the context of other coactivators. Here we have identified a previously uncharacterized integral subunit (TRAP25) of the complex that is apparently metazoan specific. An antibody that is specific for TRAP25 allowed quantitative immunodepletion of essentially all TRAP/Mediator components from HeLa nuclear extract, without detectably affecting levels of RNA polymerase II and corresponding general transcription factors. Surprisingly, the TRAP/Mediator-depleted nuclear extract displayed severely reduced levels of both basal and activator-dependent transcription from DNA templates. Both activities were efficiently restored upon readdition of purified TRAP/Mediator. Moreover, restoration of basal and activator-dependent transcription to extracts that were simultaneously depleted of TRAP/Mediator and TFIID (TBP plus the major TAFIIs) required addition of both TBP and associated TAFIIs, as well as TRAP/Mediator. These observations indicate that TAFIIs and Mediator are jointly required for both basal and activated transcription in the context of a more physiological complement of nuclear proteins. We propose a close mechanistic linkage between these components that most likely operates at the level of combined effects on the general transcription machinery and, in addition, a direct role for Mediator in relaying activation signals to this machinery.
- Open Access
- 26 February 2002
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 99 (5) , 2642-2647
The TRAP/Mediator coactivator complex interacts directly with estrogen receptors α and β through the TRAP220 subunit and directly enhances estrogen receptor function in vitro
Target gene activation by nuclear hormone receptors, including estrogen receptors (ERs), is thought to be mediated by a variety of interacting cofactors. Here we identify a number of nuclear extract-derived proteins that interact with immobilized ER ligand binding domains in a 17β-estradiol-dependent manner. The most prominent of these are components of the thyroid hormone receptor-associated protein (TRAP)/Mediator coactivator complex, which interacts with ERα and ERβ in both unfractionated nuclear extracts and purified form. Studies with extracts from TRAP220 −/− fibroblasts reveal that these interactions depend on TRAP220, a TRAP/Mediator subunit previously shown to interact with ER and other nuclear receptors in a ligand-dependent manner. The physiological relevance of the in vitro interaction is documented further by the isolation of an ERα–TRAP/Mediator complex from cultured cells expressing an epitope-tagged ERα. Finally, the complete TRAP/Mediator complex is shown to enhance ER function directly in a highly purified cell-free transcription system. These studies firmly establish a direct role for TRAP/Mediator, through TRAP220, in ER function.
- 26 February 2002
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 99 (5) , 2642-2647
Open AccessThe TRAP/Mediator coactivator complex interacts directly with estrogen receptors α and β through the TRAP220 subunit and directly enhances estrogen receptor function in vitro
Target gene activation by nuclear hormone receptors, including estrogen receptors (ERs), is thought to be mediated by a variety of interacting cofactors. Here we identify a number of nuclear extract-derived proteins that interact with immobilized ER ligand binding domains in a 17β-estradiol-dependent manner. The most prominent of these are components of the thyroid hormone receptor-associated protein (TRAP)/Mediator coactivator complex, which interacts with ERα and ERβ in both unfractionated nuclear extracts and purified form. Studies with extracts from TRAP220 −/− fibroblasts reveal that these interactions depend on TRAP220, a TRAP/Mediator subunit previously shown to interact with ER and other nuclear receptors in a ligand-dependent manner. The physiological relevance of the in vitro interaction is documented further by the isolation of an ERα–TRAP/Mediator complex from cultured cells expressing an epitope-tagged ERα. Finally, the complete TRAP/Mediator complex is shown to enhance ER function directly in a highly purified cell-free transcription system. These studies firmly establish a direct role for TRAP/Mediator, through TRAP220, in ER function.
- 1 January 2002
- Published by Springer Nature in Journal of Biomedical Science
- Vol. 9 (3) , 234-245
MCEF, the Newest Member of the AF4 Family of Transcription Factors Involved in Leukemia, Is a Positive Transcription Elongation Factor-b-Associated Protein
- 1 January 2002
- Published by Springer Nature in Journal of Biomedical Science
- Vol. 9 (3) , 234-245
MCEF, the Newest Member of the AF4 Family of Transcription Factors Involved in Leukemia, Is a Positive Transcription Elongation Factor-b-Associated Protein
- 1 October 2001
- Published by Taylor & Francis in Molecular and Cellular Biology
- Vol. 21 (20) , 6882-6894
Positive and Negative TAFII Functions That Suggest a Dynamic TFIID Structure and Elicit Synergy with TRAPs in Activator-Induced Transcription
Human transcription factor TFIID contains the TATA-binding protein (TBP) and several TBP-associated factors (TAFIIs). To elucidate the structural organization and function of TFIID, we expressed and characterized the product of a cloned cDNA encoding human TAFII135 (hTAFII135). Comparative far Western blots have shown that hTAFII135 interacts strongly with hTAFII20, moderately with hTAFII150, and weakly with hTAFII43 and hTAFII250. Consistent with these observations and with sequence relationships of hTAFII20 and hTAFII135 to histones H2B and H2A, respectively, TFIID preparations that contain higher levels of hTAFII135 also contain higher levels of hTAFII20, and the interaction between hTAFII20 and hTAFII135 is critical for human TFIID assembly in vitro. From a functional standpoint, hTAFII135 has been found to interact strongly and directly with hTFIIA and (within a complex that also contains hTBP and hTAFII250) to specifically cooperate with TFIIA to relieve TAFII250-mediated repression of TBP binding and function on core promoters. Finally, we report a functional synergism between TAFIIs and the TRAP/Mediator complex in activated transcription, manifested as hTAFII-mediated inhibition of basal transcription and a consequent TRAP requirement for both a high absolute level of activated transcription and a high and more physiological activated/basal transcription ratio. These results suggest a dynamic TFIID structure in which the switch from a basal hTAFII-enhanced repression state to an activator-mediated activated state on a promoter may be mediated in part through activator or coactivator interactions with hTAFII135.
- 1 October 2001
- Published by Taylor & Francis in Molecular and Cellular Biology
- Vol. 21 (20) , 6882-6894
Positive and Negative TAFII Functions That Suggest a Dynamic TFIID Structure and Elicit Synergy with TRAPs in Activator-Induced Transcription
Human transcription factor TFIID contains the TATA-binding protein (TBP) and several TBP-associated factors (TAFIIs). To elucidate the structural organization and function of TFIID, we expressed and characterized the product of a cloned cDNA encoding human TAFII135 (hTAFII135). Comparative far Western blots have shown that hTAFII135 interacts strongly with hTAFII20, moderately with hTAFII150, and weakly with hTAFII43 and hTAFII250. Consistent with these observations and with sequence relationships of hTAFII20 and hTAFII135 to histones H2B and H2A, respectively, TFIID preparations that contain higher levels of hTAFII135 also contain higher levels of hTAFII20, and the interaction between hTAFII20 and hTAFII135 is critical for human TFIID assembly in vitro. From a functional standpoint, hTAFII135 has been found to interact strongly and directly with hTFIIA and (within a complex that also contains hTBP and hTAFII250) to specifically cooperate with TFIIA to relieve TAFII250-mediated repression of TBP binding and function on core promoters. Finally, we report a functional synergism between TAFIIs and the TRAP/Mediator complex in activated transcription, manifested as hTAFII-mediated inhibition of basal transcription and a consequent TRAP requirement for both a high absolute level of activated transcription and a high and more physiological activated/basal transcription ratio. These results suggest a dynamic TFIID structure in which the switch from a basal hTAFII-enhanced repression state to an activator-mediated activated state on a promoter may be mediated in part through activator or coactivator interactions with hTAFII135.
- 19 July 2001
- Published by Elsevier in Mechanisms of Development
- Vol. 106 (1-2) , 203-205
Cell- and stage-specific high-level expression of TBP-related factor 2 (TRF2) during mouse spermatogenesis
- 19 July 2001
- Published by Elsevier in Mechanisms of Development
- Vol. 106 (1-2) , 203-205
Cell- and stage-specific high-level expression of TBP-related factor 2 (TRF2) during mouse spermatogenesis
- 19 December 2000
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 97 (26) , 14200-14205
A stable complex of a novel transcription factor IIB- related factor, human TFIIIB50, and associated proteins mediate selective transcription by RNA polymerase III of genes with upstream promoter elements
Transcription factor IIIB (TFIIIB) is directly involved in transcription initiation by RNA polymerase III in eukaryotes. Yeast contain a single TFIIIB activity that is comprised of the TATA-binding protein (TBP), TFIIB-related factor 1 (BRF1), and TFIIIB′′, whereas two distinct TFIIIB activities, TFIIIB-α and TFIIIB-β, have been described in human cells. Human TFIIIB-β is required for transcription of genes with internal promoter elements, and contains TBP, a TFIIIB′′ homologue (TFIIIB150), and a BRF1 homologue (TFIIIB90), whereas TFIIIB-α is required for transcription of genes with promoter elements upstream of the initiation site. Here we describe the identification, cloning, and characterization of TFIIIB50, a novel homologue of TFIIB and TFIIIB90. TFIIIB50 and tightly associated factors, along with TBP and TFIIIB150, reconstitute human TFIIIB-α activity. Thus, higher eukaryotes, in contrast to the yeast Saccharomyces cerevisiae , have evolved two distinct TFIIB-related factors that mediate promoter selectivity by RNA polymerase III.
- 19 December 2000
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 97 (26) , 14200-14205
A stable complex of a novel transcription factor IIB- related factor, human TFIIIB50, and associated proteins mediate selective transcription by RNA polymerase III of genes with upstream promoter elements
Transcription factor IIIB (TFIIIB) is directly involved in transcription initiation by RNA polymerase III in eukaryotes. Yeast contain a single TFIIIB activity that is comprised of the TATA-binding protein (TBP), TFIIB-related factor 1 (BRF1), and TFIIIB′′, whereas two distinct TFIIIB activities, TFIIIB-α and TFIIIB-β, have been described in human cells. Human TFIIIB-β is required for transcription of genes with internal promoter elements, and contains TBP, a TFIIIB′′ homologue (TFIIIB150), and a BRF1 homologue (TFIIIB90), whereas TFIIIB-α is required for transcription of genes with promoter elements upstream of the initiation site. Here we describe the identification, cloning, and characterization of TFIIIB50, a novel homologue of TFIIB and TFIIIB90. TFIIIB50 and tightly associated factors, along with TBP and TFIIIB150, reconstitute human TFIIIB-α activity. Thus, higher eukaryotes, in contrast to the yeast Saccharomyces cerevisiae , have evolved two distinct TFIIB-related factors that mediate promoter selectivity by RNA polymerase III.
- Open Access
- 15 December 2000
- Published by Springer Nature in The EMBO Journal
- Vol. 19 (24) , 6823-6832
Nuclear factor 1 (NF1) affects accurate termination and multiple‐round transcription by human RNA polymerase III
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.
- 15 December 2000
- Published by Springer Nature in The EMBO Journal
- Vol. 19 (24) , 6823-6832
Open AccessNuclear factor 1 (NF1) affects accurate termination and multiple‐round transcription by human RNA polymerase III
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.
- Open Access
- 15 June 2000
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 164 (12) , 6372-6379
Functional Analysis of the OCA-B Promoter
OCA-B was identified as a B cell-specific coactivator that functions with either Oct-1 or Oct-2 to mediate efficient cell type-specific transcription via the octamer site (ATGCAAAT) both in vivo and in vitro. Mice lacking OCA-B exhibit normal Ag-independent B cell maturation. In contrast, Ag-dependent functions, including production of secondary Ig isotypes and germinal center formation, are greatly affected. To better understand OCA-B expression and, ultimately, the defects observed in the OCA-B knockout mice, we have cloned the OCA-B promoter and examined its function in both transformed and primary B cells. We show here that the OCA-B promoter is developmentally regulated, with activity increasing throughout B cell differentiation. Through physical and functional assays, we have found an activating transcription factor/cAMP response element binding protein binding site (or cAMP response element) that is crucial for OCA-B promoter activity. Furthermore, we demonstrate that IL-4 and anti-CD40 induce both the OCA-B promoter and octamer-dependent promoters, thus implicating OCA-B in B cell signaling events in the nucleus.
- 15 June 2000
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 164 (12) , 6372-6379
Open AccessFunctional Analysis of the OCA-B Promoter
OCA-B was identified as a B cell-specific coactivator that functions with either Oct-1 or Oct-2 to mediate efficient cell type-specific transcription via the octamer site (ATGCAAAT) both in vivo and in vitro. Mice lacking OCA-B exhibit normal Ag-independent B cell maturation. In contrast, Ag-dependent functions, including production of secondary Ig isotypes and germinal center formation, are greatly affected. To better understand OCA-B expression and, ultimately, the defects observed in the OCA-B knockout mice, we have cloned the OCA-B promoter and examined its function in both transformed and primary B cells. We show here that the OCA-B promoter is developmentally regulated, with activity increasing throughout B cell differentiation. Through physical and functional assays, we have found an activating transcription factor/cAMP response element binding protein binding site (or cAMP response element) that is crucial for OCA-B promoter activity. Furthermore, we demonstrate that IL-4 and anti-CD40 induce both the OCA-B promoter and octamer-dependent promoters, thus implicating OCA-B in B cell signaling events in the nucleus.
- Open Access
- 1 March 2000
- Published by Springer Nature in The EMBO Journal
- Vol. 19 (5) , 956-963
TIP30 has an intrinsic kinase activity required for up‐regulation of a subset of apoptotic genes
CC3 is a metastasis suppressor that inhibits metastasis of the variant small cell lung carcinoma (v‐SCLC) by predisposing cells to apoptosis. The same protein was also reported as a cellular cofactor, TIP30, which stimulates HIV‐1 Tat‐activated transcription by interacting with both Tat and RNA polymerase II. We report here that TIP30/CC3 is a novel serine/threonine kinase. It phosphorylates the heptapeptide repeats of the C‐terminal domain (CTD) of the largest RNA polymerase II subunit in a Tat‐dependent manner. Amino acid substitutions in the putative ATP binding motif that abolish the TIP30 kinase activity also inhibit the ability of TIP30 to enhance Tat‐activated transcription or to sensitize NIH 3T3 and v‐SCLC cells to apoptosis. Furthermore, ectopic expression of TIP30/CC3 in v‐SCLC cells induces expression of a number of genes that include the apoptosis‐related genes Bad and Siva, as well as metastasis suppressor NM23‐H2. These data demonstrate a molecular mechanism for TIP30/CC3 function and suggest a novel pathway for regulating apoptosis.
- 1 March 2000
- Published by Springer Nature in The EMBO Journal
- Vol. 19 (5) , 956-963
Open AccessTIP30 has an intrinsic kinase activity required for up‐regulation of a subset of apoptotic genes
CC3 is a metastasis suppressor that inhibits metastasis of the variant small cell lung carcinoma (v‐SCLC) by predisposing cells to apoptosis. The same protein was also reported as a cellular cofactor, TIP30, which stimulates HIV‐1 Tat‐activated transcription by interacting with both Tat and RNA polymerase II. We report here that TIP30/CC3 is a novel serine/threonine kinase. It phosphorylates the heptapeptide repeats of the C‐terminal domain (CTD) of the largest RNA polymerase II subunit in a Tat‐dependent manner. Amino acid substitutions in the putative ATP binding motif that abolish the TIP30 kinase activity also inhibit the ability of TIP30 to enhance Tat‐activated transcription or to sensitize NIH 3T3 and v‐SCLC cells to apoptosis. Furthermore, ectopic expression of TIP30/CC3 in v‐SCLC cells induces expression of a number of genes that include the apoptosis‐related genes Bad and Siva, as well as metastasis suppressor NM23‐H2. These data demonstrate a molecular mechanism for TIP30/CC3 function and suggest a novel pathway for regulating apoptosis.